Brian Lian, President & CEO at Viking Therapeutics, Inc. (VKTX), sold 85,000 shares at $24.45 ($2.1M) on 2024-01-31, disclosed to the SEC on 2024-01-31.
Scheduled sale ($2.1M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.45 | 40,000 | $978K | 46.6% |
| 2 | $24.95 | 45,000 | $1.1M | 53.4% |
| Total | $24.71 avg | 85,000 | $2.1M | 100% |
| Filing → |
| VKTX | SELL | 2025-10-28 | $2.7M | — | Filing → |
| VKTX | SELL | 2025-07-03 | $1.5M | — | Filing → |
| VKTX | SELL | 2025-01-06 | $15.8M | — | Filing → |